Equity Overview
Price & Market Data
Price: $1.65
Daily Change: +$0.01 / 0.61%
Daily Range: $1.65 - $1.67
Market Cap: $2,341,870
Daily Volume: 877
Performance Metrics
1 Week: -4.09%
1 Month: -10.38%
3 Months: -74.28%
6 Months: -83.53%
1 Year: -90.89%
YTD: -70.18%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.